Randomized controlled intervention in cardiovascular drug treatment in nursing homes

Pharmacoepidemiology and Drug Safety

Volumn 12, Issue 7, 2003, Pages 589-593

  Ulfvarson, Johanna ^a   Adami, Johanna ^b   Ullman, Bengt ^b   Wredling, Regina ^a   Reilly, Marie ^a   von Bahr, Christer ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Adverse drug reactions; Drug treatment; Drug utilization; Elderly; Heart failure; Medical audit; Nursing home

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ACETYLSALICYLIC ACID; ALLOPURINOL; AMILORIDE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; FUROSEMIDE; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM SPARING DIURETIC AGENT; PSYCHOTROPIC AGENT; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; WARFARIN;

AGED; ANGINA PECTORIS; CARDIOLOGY; CARDIOVASCULAR DISEASE; CLINICAL PHARMACOLOGY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DAILY LIFE ACTIVITY; DIAGNOSTIC PROCEDURE; DRUG COST; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG UTILIZATION; DRUG WITHDRAWAL; ELDERLY CARE; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MUSCLE HYPERTONIA; NURSING HOME; OUTCOMES RESEARCH; PHYSICIAN; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REVIEW; SCORING SYSTEM; SIDE EFFECT; SYMPTOMATOLOGY; VALVULAR HEART DISEASE;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; FEMALE; HEALTH SERVICES FOR THE AGED; HOMES FOR THE AGED; HUMANS; MALE; MEDICAL AUDIT; NURSING HOMES; PHYSICIAN'S PRACTICE PATTERNS; QUALITY OF LIFE; SWEDEN; TREATMENT OUTCOME;

EID: 0141505938     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.855     Document Type: Review

References (17)

1. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991; 151: 1825-1832.
2. Fincke B, Miller D, Spiro A. The interaction of patient perception of overmedication with drug compliance and side effects. J Ger Intern Med 1998; 13: 182-185.
3. Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivela SL, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 2002; 55(8): 809-817.
4. Ruths S, Straand J, Nygaard HA, Hodneland F. Drug treatment of heart failure-do nursing-home residents deserve better? Scand J Prim Health Care 2000; 18: 26-31.
5. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001; 31: 199-205.
6. Gurwitz JH, Field TS, Avorn J, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109: 87-94.
7. Lindley CM, Tully MP, Paramsothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 21: 294-300.
8. Schmidt I, Claesson CB, Westerholm B, Nilsson LG, Svarstad BL. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc 1998; 46: 77-82.
9. Furniss L, Burns A, Lloyd Craig SK, Scobie S, Cooke J, Faragher B. Effects of a pharmacist's medication review in nursing homes. Br J Psychiatry 2000; 176: 563-567.
10. Hulter-Åsberg K. ADL-trappan. 1990. Lund Studentlitteratur. (In Swedish).
11. Forsberg C, Björwell H. Swedish population norms for the GHIR, HI and STAI-state. Qual Life Res 1993; 2(5): 349-356.
12. Nordström GM, Nyman CR, Theorell T. Psycho-social adjustment and general state of health in patients with urinary diversion. Scand J Urol Nephrol 1992; 26: 139-147.
13. Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick AD, McDevitt DG, Struthers AD. Echocardiography in chronic heart failure in the community. Q J Med 1993; 286(1): 17-23.
14. Blomqvist K, Örtoft K, Åkerlind I. NYHA-systemet opålitligt då annan sjukdom get liknande symtombild. Lakartidn 2001; 98(22): 2713-2717. (In Swedish).
15. Gambassi G, Lapane KL, Sgadari A, et al. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. Arch Intern Med 2000; 160: 53-60.
16. Mason M, Young P, Freemantle N, Hobbs R. Safety and costs of initiating angiotensin converting enzyme inhibitors for heart failure in primary care: analysis of individual patient data from studies of left ventricular dysfunction. Br Med J 2000; 321: 1113-1116.
17. Zhan C, Sangl J, Bierman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly. JAMA 2001; 286(22): 2823-2829.